| On-demand preexposure prophylaxis in men at high risk for HIV-1 infection JM Molina, C Capitant, B Spire, G Pialoux, L Cotte, I Charreau, ... New England Journal of Medicine 373 (23), 2237-2246, 2015 | 1923 | 2015 |
| Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study A Sáez-Cirión, C Bacchus, L Hocqueloux, V Avettand-Fenoel, I Girault, ... PLoS pathogens 9 (3), e1003211, 2013 | 1198 | 2013 |
| Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management AMJ Wensing, DA Van De Vijver, G Angarano, B Åsjö, C Balotta, E Boeri, ... The Journal of infectious diseases 192 (6), 958-966, 2005 | 555 | 2005 |
| Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study JM Molina, I Charreau, B Spire, L Cotte, J Chas, C Capitant, C Tremblay, ... The lancet HIV 4 (9), e402-e410, 2017 | 519 | 2017 |
| HIV controllers: a homogeneous group of HIV-1—infected patients with spontaneous control of viral replication O Lambotte, F Boufassa, Y Madec, A Nguyen, C Goujard, L Meyer, ... Clinical Infectious Diseases 41 (7), 1053-1056, 2005 | 506 | 2005 |
| Reduced blood CD123+ (lymphoid) and CD11c+ (myeloid) dendritic cell numbers in primary HIV-1 infection J Pacanowski, S Kahi, M Baillet, P Lebon, C Deveau, C Goujard, L Meyer, ... Blood, The Journal of the American Society of Hematology 98 (10), 3016-3021, 2001 | 419 | 2001 |
| Rapid Progression to AIDS in HIV+ Individuals with a Structural Variant of the Chemokine Receptor CX3CR1 S Faure, L Meyer, D Costagliola, C Vaneensberghe, E Genin, B Autran, ... Science 287 (5461), 2274-2277, 2000 | 405 | 2000 |
| Effects of CCR5-Δ 32, CCR2-64I, and SDF-1 3′A Alleles on HIV-1 Disease Progression: An International Meta-Analysis of Individual-Patient Data JPA Ioannidis, PS Rosenberg, JJ Goedert, LJ Ashton, TL Benfield, ... Annals of internal medicine 135 (9), 782-795, 2001 | 398 | 2001 |
| Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial JM Molina, I Charreau, C Chidiac, G Pialoux, E Cua, C Delaugerre, ... The Lancet Infectious Diseases 18 (3), 308-317, 2018 | 371 | 2018 |
| HIV-1 infection in an individual homozygous for CCR5Delta32. I Theodorou, L Meyer The Lancet 349 (9060), 1219-1220, 1997 | 305 | 1997 |
| CD8+ T cells specific for EBV, cytomegalovirus, and influenza virus are activated during primary HIV infection JM Doisne, A Urrutia, C Lacabaratz-Porret, C Goujard, L Meyer, ML Chaix, ... The Journal of Immunology 173 (4), 2410-2418, 2004 | 283 | 2004 |
| Response to combination antiretroviral therapy: variation by age Collaboration of Observational HIV Epidemiological Research Europe (COHERE ... Aids 22 (12), 1463-1473, 2008 | 281 | 2008 |
| Time From Human Immunodeficiency Virus Seroconversion to Reaching CD4+ Cell Count Thresholds <200, <350, and <500 Cells/mm3: Assessment of Need … S Lodi, A Phillips, G Touloumi, R Geskus, L Meyer, R Thiébaut, ... Clinical infectious diseases 53 (8), 817-825, 2011 | 269 | 2011 |
| CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients C Goujard, M Bonarek, L Meyer, F Bonnet, ML Chaix, C Deveau, M Sinet, ... Clinical Infectious Diseases 42 (5), 709-715, 2006 | 269 | 2006 |
| Population-based HIV-1 incidence in France, 2003–08: a modelling analysis S Le Vu, Y Le Strat, F Barin, J Pillonel, F Cazein, V Bousquet, S Brunet, ... The Lancet infectious diseases 10 (10), 682-687, 2010 | 242 | 2010 |
| Harmonizing genetic ancestry and self-identified race/ethnicity in genome-wide association studies H Fang, Q Hui, J Lynch, J Honerlaw, TL Assimes, J Huang, M Vujkovic, ... The American Journal of Human Genetics 105 (4), 763-772, 2019 | 235 | 2019 |
| Distinct genetic loci control plasma HIV-RNA and cellular HIV-DNA levels in HIV-1 infection: the ANRS Genome Wide Association 01 study C Dalmasso, W Carpentier, L Meyer, C Rouzioux, C Goujard, ML Chaix, ... PloS one 3 (12), e3907, 2008 | 226 | 2008 |
| Long-term mortality in HIV-positive individuals virally suppressed for> 3 years with incomplete CD4 recovery FN Engsig, R Zangerle, O Katsarou, F Dabis, P Reiss, J Gill, K Porter, ... Clinical infectious diseases 58 (9), 1312-1321, 2014 | 217 | 2014 |
| HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis D Sauce, M Larsen, S Fastenackels, M Pauchard, H Ait-Mohand, ... Blood, The Journal of the American Society of Hematology 117 (19), 5142-5151, 2011 | 211 | 2011 |
| Early Levels of HIV-1 DNA in Peripheral Blood Mononuclear Cells Are Predictive of Disease Progression Independently of HIV-1 RNA Levels and CD4+ T Cell … C Rouzioux, JB Hubert, M Burgard, C Deveau, C Goujard, M Bary, ... The Journal of infectious diseases 192 (1), 46-55, 2005 | 207 | 2005 |